Headquartered in Planegg-Martinsried near Munich/Germany, 4SC is an innovative biotech company with a strong focus on clinical development. We discover and develop targeted small molecule drugs with an epigenetic mode of action for the treatment of cancer in indications with a high unmet medical need and major economic potential. In doing so, we wish to offer affected patients treatment options that are more effective and better tolerated to provide a better quality of life and create value for our shareholders, partners and employees.
Planegg, DE
Size (employees)
39 (est)-11%
4SC was founded in 1997 and is headquartered in Planegg, DE
Report incorrect company information

Key People/Management at 4SC

Jason Loveridge Ph.D

Jason Loveridge Ph.D

Chief Executive Officer (CEO) Chairman of the Management Board
Frank Hermann M.D

Frank Hermann M.D

Chief Development Officer (CDO)
Susanne Danhauser-Riedl M.D

Susanne Danhauser-Riedl M.D

Chief Medical Officer (CMO)

4SC Office Locations

4SC has an office in Planegg
Planegg, DE (HQ)
19A Am Klopferspitz
Show all (1)
Report incorrect company information

4SC Financials and Metrics

4SC Financials

Market capitalization (30-Oct-2017)

94.3 m

Closing share price (30-Oct-2017)

4SC's current market capitalization is €94.3 m.
Show all financial metrics
Report incorrect company information